fbpx Skip to main content

BioCommunique Article

Bringing you the latest financial and strategic news from top leaders in life science.

Remdesivir Receives FDA Emergency Use Authorization; Arena Pharmaceuticals Announces Launch of Longboard Pharmaceuticals With $56M Financing; Cue Health Receives $481M Award

  • 2020-10-29T19:00:00.000+0000
  • California
  • Author: Lauren Panetta

10/29/20 – Mission Bio

Mission Bio Launches Single-cell Multi-omics System for Faster, More Successful Development of Precision Cancer Therapies

10/29/20 – Thermo Fisher Scientific

Thermo Fisher Scientific Extends Collaboration to Advance Biopharmaceutical Discovery and Development

10/29/20 – Biocept

Biocept Provides Update on COVID-19 Testing with More than 80,000 Samples Received

10/29/20 – Cellares

Cellares Welcomes Fred Hutchinson Cancer Research Center Into Its Early Access Partnership Program

10/29/20 – Zeriogo Health

Comprehensive At-Home Treatment and Coaching Solution for Chronic Skin Conditions Rebrands as Zerigo Health

10/29/20 – Sorrento Therapeutics

Sorrento Announces That Intranasal Administration of COVI-AMG™ Neutralizing Antibody Prevented COVID-19 Disease Progression in Infected Hamsters Following SARS-CoV-2 Infection

10/28/20 – FierceBiotech

Bristol Myers, insitro ally to apply machine learning to ALS R&D

10/28/20 – Invitae

Research Highlights Frequency of Genetic Risk Factors Among Men with Prostate Cancer, Suggests Role for Broader Screening

10/28/20 – ChemoCentryx

ChemoCentryx Announces Positive Topline Results of Phase II AURORA Clinical Trial of Avacopan in the Treatment of Hidradenitis Suppurativa (HS)

10/28/20 – Arena Pharmaceuticals

Arena Pharmaceuticals Announces Launch of Longboard Pharmaceuticals With $56M Financing, Building a Novel Neuroscience Drug Development Company

10/27/20 – Exelixis

Exelixis Announces Takeda and Ono Submit Supplemental Application for CABOMETYX® (cabozantinib) in Combination with OPDIVO® (nivolumab) for the Treatment of Unresectable, Advanced or Metastatic Renal Cell Carcinoma in Japan

10/27/20 – Oncolytics Biotech

Oncolytics Biotech® Collaborates with Roche and AIO to Initiate a Phase 1/2 Gastrointestinal Cancer Trial Combining Pelareorep with Roche's Anti-PD-L1 Checkpoint Inhibitor

10/27/20 – Histogen

Histogen and Amerimmune Enter into a Collaborative Development and Commercialization Agreement for Emricasan in the Treatment of COVID-19

10/27/20 – ImmunoPrecise Antibodies

ImmunoPrecise and Twist Bioscience Announce Collaboration for the Creation of Novel, Therapeutic Products

10/27/20 – SDSU

SDSU Faculty Lead Collaborative COVID-19 Research Efforts: Health Care

10/27/20 – Twist Biosciences

Twist Bioscience Collaborates With Beyond Earth to Launch Artwork Stored in DNA Into Space

10/26/20 – Boundless Bio

Boundless Bio Presents Research Showcasing its Imaging and Single-Cell Sequencing Platform for Extrachromosomal DNA (ecDNA) Detection at the 2020 American Society of Human Genetics (ASHG) Virtual Annual Meeting

10/26/20 – AnaptysBio

AnaptysBio and GlaxoSmithKline: Amend Strategic Immuno-Oncology Collaboration

10/26/20 – BioSpace

FibroGen Provides More Support for Roxadustat in Anemia Associated with Kidney Disease

10/26/20 – San Diego Business Journal

Cue Receives $481M Award

10/23/20 – Ligand Pharmaceuticals

Ligand's Captisol Technology Plays Key Role in the Manufacture of Gilead's Veklury, the First FDA-Approved COVID-19 Treatment

10/22/20 – The San Diego Union-Tribune

FDA approves first COVID-19 drug: antiviral remdesivir

10/22/20 – IDEAYA Biosciences

IDEAYA Announces Partnership With The Broad Institute And Advancement Of Synthetic Lethality Programs And Platform

10/22/20 – Pacific Biosciences of California

Invitae and Pacific Biosciences Collaborate to Develop Whole Genome Sequencing-Based Assays for Pediatric Epilepsy Diagnostics